Shutterstock
By André O. Hudson, Fidelma Fitzpatrick, Juliana Côrrea, Lori L. Burrows, Raúl Rivas González, Roy Robins-Browne, Yori Yuliandra
Monday, October 16, 2023 9:10 AM UTC
Almost since antibiotics were first discovered, we’ve been aware bacteria can learn how to overcome these medicines, a phenomenon known as antimicrobial resistance.
The World Health Organization says we’re currently losing to the bugs, with resistance increasing and too few new antibiotics in the pipeline.
We wanted to know whether experts around the world think we will still have effective antibiotics in 50 years. Seven out of seven experts said yes.
Sign up for daily updates for the most important
stories unfolding in the global economy.
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
